Your browser doesn't support javascript.
loading
Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK.
Ming, D K; Otter, J A; Ghani, R; Brannigan, E T; Boonyasiri, A; Mookerjee, S; Gilchrist, M; Holmes, A H; Davies, F.
Afiliação
  • Ming DK; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK. Electronic address: damien.ming@doctors.org.uk.
  • Otter JA; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Ghani R; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Brannigan ET; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Boonyasiri A; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.
  • Mookerjee S; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Gilchrist M; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Holmes AH; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Davies F; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
J Hosp Infect ; 102(1): 95-97, 2019 05.
Article em En | MEDLINE | ID: mdl-30716340
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Sepse / Gerenciamento Clínico / Infecções por Enterobacteriaceae / Enterobacteriáceas Resistentes a Carbapenêmicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Hosp Infect Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Sepse / Gerenciamento Clínico / Infecções por Enterobacteriaceae / Enterobacteriáceas Resistentes a Carbapenêmicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Hosp Infect Ano de publicação: 2019 Tipo de documento: Article